Ligands and receptors of the TNF superfamily are decreased in major depression and during early antidepressant therapy

Frank M. Schmidt; Jenny Koch; Claudia Nowak; Lesca M. Holdt; Daniel Teupser; Ulrich Hegerl; Hubertus Himmerich

doi:10.1016/j.jpsychires.2019.09.010

Ligands and receptors of the TNF superfamily are decreased in major depression and during early antidepressant therapy

Frank M. Schmidt^*, Jenny Koch, Claudia Nowak, Lesca M. Holdt, Daniel Teupser, Ulrich Hegerl, Hubertus Himmerich

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

20 Citations (Scopus)

366 Downloads (Pure)

Abstract

Background: The up-regulation of pro-inflammatory agents, amongst them tumor necrosis factor (TNF), may represent low-grade inflammation in major depression. To further elucidate inflammatory mechanisms related to TNF in depression, the aim of the current study was to investigate the involvement of ligands and receptors of the TNF/TNF-receptor-superfamily yet un- or little explored in major depression.

Methods: Serum levels of ligands (TNF, TNF-related weak inducer of apoptosis [TWEAK], B-cell activating factor [BAFF], tumor necrosis factor superfamily member 14 [TNFSF14; LIGHT], A proliferation-inducing ligand [APRIL]) and receptor molecules (TNF receptor superfamily member 8 [TNFRSF8; sCD30], soluble TNF receptor type 1 [sTNFR1] and type 2 [sTNFR2]) of the TNF/TNF-receptor-superfamily were measured in 50 unmedicated patients suffering from major depression and 48 healthy controls and were reassessed in 37 of the depressed patients two weeks after the initiation of antidepressive treatment.

Results: In comparison to the healthy controls, the interrelated serum levels of TWEAK, BAFF, TNFSF8, sTNFR1 and sTNFR2 were reduced both in the unmedicated and medicated depressed patients. Serum levels of BAFF and TNF significantly increased during the initiation of antidepressive treatment. In the combined sample of unmedicated depressed and healthy controls, but not the separate groups, scores of the BDI-II inversely correlated with levels of TWEAK, BAFF, sTNFR1, sTNFR2 and TNFSF8.

Conclusion: The current findings give evidence for a role of the TNF/TNF-receptor-superfamily in the pathophysiology of major depression that may involve reduced tissue regeneration and neurogenesis rather than an acceleration of pro-inflammatory pathways.

Original language	English
Pages (from-to)	116-121
Number of pages	6
Journal	Journal of psychiatric research
Volume	119
Issue number	0
Early online date	24 Sept 2019
DOIs	https://doi.org/10.1016/j.jpsychires.2019.09.010
Publication status	Published - 1 Dec 2019

Keywords

Cytokines
Inflammation hypothesis
Major depression
TNF superfamily

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jpsychires.2019.09.010

Ligands and receptors of_SCHMIDT_Accepted23September2019Publishedonline24September2019_GREEN AAM (CC BY-NC-ND)Accepted author manuscript, 149 KBLicence: CC BY-NC-ND

Cite this

@article{89a9769895794658916f4880772515c0,

title = "Ligands and receptors of the TNF superfamily are decreased in major depression and during early antidepressant therapy",

abstract = "Background: The up-regulation of pro-inflammatory agents, amongst them tumor necrosis factor (TNF), may represent low-grade inflammation in major depression. To further elucidate inflammatory mechanisms related to TNF in depression, the aim of the current study was to investigate the involvement of ligands and receptors of the TNF/TNF-receptor-superfamily yet un- or little explored in major depression. Methods: Serum levels of ligands (TNF, TNF-related weak inducer of apoptosis [TWEAK], B-cell activating factor [BAFF], tumor necrosis factor superfamily member 14 [TNFSF14; LIGHT], A proliferation-inducing ligand [APRIL]) and receptor molecules (TNF receptor superfamily member 8 [TNFRSF8; sCD30], soluble TNF receptor type 1 [sTNFR1] and type 2 [sTNFR2]) of the TNF/TNF-receptor-superfamily were measured in 50 unmedicated patients suffering from major depression and 48 healthy controls and were reassessed in 37 of the depressed patients two weeks after the initiation of antidepressive treatment. Results: In comparison to the healthy controls, the interrelated serum levels of TWEAK, BAFF, TNFSF8, sTNFR1 and sTNFR2 were reduced both in the unmedicated and medicated depressed patients. Serum levels of BAFF and TNF significantly increased during the initiation of antidepressive treatment. In the combined sample of unmedicated depressed and healthy controls, but not the separate groups, scores of the BDI-II inversely correlated with levels of TWEAK, BAFF, sTNFR1, sTNFR2 and TNFSF8. Conclusion: The current findings give evidence for a role of the TNF/TNF-receptor-superfamily in the pathophysiology of major depression that may involve reduced tissue regeneration and neurogenesis rather than an acceleration of pro-inflammatory pathways.",

keywords = "Cytokines, Inflammation hypothesis, Major depression, TNF superfamily",

author = "Schmidt, {Frank M.} and Jenny Koch and Claudia Nowak and Holdt, {Lesca M.} and Daniel Teupser and Ulrich Hegerl and Hubertus Himmerich",

year = "2019",

month = dec,

day = "1",

doi = "10.1016/j.jpsychires.2019.09.010",

language = "English",

volume = "119",

pages = "116--121",

journal = "Journal of psychiatric research",

issn = "0022-3956",

publisher = "Elsevier",

number = "0",

}

TY - JOUR

T1 - Ligands and receptors of the TNF superfamily are decreased in major depression and during early antidepressant therapy

AU - Schmidt, Frank M.

AU - Koch, Jenny

AU - Nowak, Claudia

AU - Holdt, Lesca M.

AU - Teupser, Daniel

AU - Hegerl, Ulrich

AU - Himmerich, Hubertus

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Background: The up-regulation of pro-inflammatory agents, amongst them tumor necrosis factor (TNF), may represent low-grade inflammation in major depression. To further elucidate inflammatory mechanisms related to TNF in depression, the aim of the current study was to investigate the involvement of ligands and receptors of the TNF/TNF-receptor-superfamily yet un- or little explored in major depression. Methods: Serum levels of ligands (TNF, TNF-related weak inducer of apoptosis [TWEAK], B-cell activating factor [BAFF], tumor necrosis factor superfamily member 14 [TNFSF14; LIGHT], A proliferation-inducing ligand [APRIL]) and receptor molecules (TNF receptor superfamily member 8 [TNFRSF8; sCD30], soluble TNF receptor type 1 [sTNFR1] and type 2 [sTNFR2]) of the TNF/TNF-receptor-superfamily were measured in 50 unmedicated patients suffering from major depression and 48 healthy controls and were reassessed in 37 of the depressed patients two weeks after the initiation of antidepressive treatment. Results: In comparison to the healthy controls, the interrelated serum levels of TWEAK, BAFF, TNFSF8, sTNFR1 and sTNFR2 were reduced both in the unmedicated and medicated depressed patients. Serum levels of BAFF and TNF significantly increased during the initiation of antidepressive treatment. In the combined sample of unmedicated depressed and healthy controls, but not the separate groups, scores of the BDI-II inversely correlated with levels of TWEAK, BAFF, sTNFR1, sTNFR2 and TNFSF8. Conclusion: The current findings give evidence for a role of the TNF/TNF-receptor-superfamily in the pathophysiology of major depression that may involve reduced tissue regeneration and neurogenesis rather than an acceleration of pro-inflammatory pathways.

AB - Background: The up-regulation of pro-inflammatory agents, amongst them tumor necrosis factor (TNF), may represent low-grade inflammation in major depression. To further elucidate inflammatory mechanisms related to TNF in depression, the aim of the current study was to investigate the involvement of ligands and receptors of the TNF/TNF-receptor-superfamily yet un- or little explored in major depression. Methods: Serum levels of ligands (TNF, TNF-related weak inducer of apoptosis [TWEAK], B-cell activating factor [BAFF], tumor necrosis factor superfamily member 14 [TNFSF14; LIGHT], A proliferation-inducing ligand [APRIL]) and receptor molecules (TNF receptor superfamily member 8 [TNFRSF8; sCD30], soluble TNF receptor type 1 [sTNFR1] and type 2 [sTNFR2]) of the TNF/TNF-receptor-superfamily were measured in 50 unmedicated patients suffering from major depression and 48 healthy controls and were reassessed in 37 of the depressed patients two weeks after the initiation of antidepressive treatment. Results: In comparison to the healthy controls, the interrelated serum levels of TWEAK, BAFF, TNFSF8, sTNFR1 and sTNFR2 were reduced both in the unmedicated and medicated depressed patients. Serum levels of BAFF and TNF significantly increased during the initiation of antidepressive treatment. In the combined sample of unmedicated depressed and healthy controls, but not the separate groups, scores of the BDI-II inversely correlated with levels of TWEAK, BAFF, sTNFR1, sTNFR2 and TNFSF8. Conclusion: The current findings give evidence for a role of the TNF/TNF-receptor-superfamily in the pathophysiology of major depression that may involve reduced tissue regeneration and neurogenesis rather than an acceleration of pro-inflammatory pathways.

KW - Cytokines

KW - Inflammation hypothesis

KW - Major depression

KW - TNF superfamily

UR - http://www.scopus.com/inward/record.url?scp=85073106802&partnerID=8YFLogxK

U2 - 10.1016/j.jpsychires.2019.09.010

DO - 10.1016/j.jpsychires.2019.09.010

M3 - Article

AN - SCOPUS:85073106802

SN - 0022-3956

VL - 119

SP - 116

EP - 121

JO - Journal of psychiatric research

JF - Journal of psychiatric research

IS - 0

ER -

Ligands and receptors of the TNF superfamily are decreased in major depression and during early antidepressant therapy

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this